78 related articles for article (PubMed ID: 18951991)
1. The effect of nitric oxide on vaccinia virus-encoded ribonucleotide reductase.
Fujikura Y; Kudlackova P; Vokurka M; Krijt J; Melkova Z
Nitric Oxide; 2009 Mar; 20(2):114-21. PubMed ID: 18951991
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of vaccinia virus DNA replication by inducible expression of nitric oxide synthase.
Mĕlková Z; Esteban M
J Immunol; 1995 Dec; 155(12):5711-8. PubMed ID: 7499858
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication.
Hagen CJ; Titong A; Sarnoski EA; Verardi PH
Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294
[TBL] [Abstract][Full Text] [Related]
4. Acidic C terminus of vaccinia virus DNA-binding protein interacts with ribonucleotide reductase.
Davis RE; Mathews CK
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):745-9. PubMed ID: 7678464
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.
Gammon DB; Gowrishankar B; Duraffour S; Andrei G; Upton C; Evans DH
PLoS Pathog; 2010 Jul; 6(7):e1000984. PubMed ID: 20628573
[TBL] [Abstract][Full Text] [Related]
6. Roles of vaccinia virus ribonucleotide reductase and glutaredoxin in DNA precursor biosynthesis.
Rajagopal I; Ahn BY; Moss B; Mathews CK
J Biol Chem; 1995 Nov; 270(46):27415-8. PubMed ID: 7499196
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus ribonucleotide reductase. Correlation between deoxyribonucleotide supply and demand.
Howell ML; Roseman NA; Slabaugh MB; Mathews CK
J Biol Chem; 1993 Apr; 268(10):7155-62. PubMed ID: 8463252
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.
Kwon NS; Stuehr DJ; Nathan CF
J Exp Med; 1991 Oct; 174(4):761-7. PubMed ID: 1717630
[TBL] [Abstract][Full Text] [Related]
9. Intracellular chelation of iron by bipyridyl inhibits DNA virus replication: ribonucleotide reductase maturation as a probe of intracellular iron pools.
Romeo AM; Christen L; Niles EG; Kosman DJ
J Biol Chem; 2001 Jun; 276(26):24301-8. PubMed ID: 11301321
[TBL] [Abstract][Full Text] [Related]
10. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo.
Child SJ; Palumbo GJ; Buller RM; Hruby DE
Virology; 1990 Feb; 174(2):625-9. PubMed ID: 2154895
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the replication apparatus and phosphorus-containing metabolite pool in experimental tumors in animals during development].
Gorbacheva LB; Gudtsova KV; Dederer LIu; Sokolova IS; Sibel'dina LA; Shkarin PIu
Vopr Med Khim; 1991; 37(6):33-6. PubMed ID: 1812611
[TBL] [Abstract][Full Text] [Related]
12. Mouse ribonucleotide reductase control: influence of substrate binding upon interactions with allosteric effectors.
Chimploy K; Mathews CK
J Biol Chem; 2001 Mar; 276(10):7093-100. PubMed ID: 11099495
[TBL] [Abstract][Full Text] [Related]
13. Vaccinia virus induces ribonucleotide reductase in primate cells.
Slabaugh MB; Johnson TL; Mathews CK
J Virol; 1984 Nov; 52(2):507-14. PubMed ID: 6387175
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
Parrish S; Moss B
J Virol; 2007 Dec; 81(23):12973-8. PubMed ID: 17881455
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus.
Petrowsky H; Roberts GD; Kooby DA; Burt BM; Bennett JJ; Delman KA; Stanziale SF; Delohery TM; Tong WP; Federoff HJ; Fong Y
J Virol; 2001 Aug; 75(15):7050-8. PubMed ID: 11435585
[TBL] [Abstract][Full Text] [Related]
16. Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha.
Backes S; Sperling KM; Zwilling J; Gasteiger G; Ludwig H; Kremmer E; Schwantes A; Staib C; Sutter G
J Gen Virol; 2010 Feb; 91(Pt 2):470-82. PubMed ID: 19846675
[TBL] [Abstract][Full Text] [Related]
17. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA
J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase.
Slabaugh MB; Mathews CK
J Virol; 1986 Nov; 60(2):506-14. PubMed ID: 3534300
[TBL] [Abstract][Full Text] [Related]
19. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
Albert DA; Gudas LJ
J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
[TBL] [Abstract][Full Text] [Related]
20. Analysis of in vitro activities of herpes simplex virus type 1 UL42 mutant proteins: correlation with in vivo function.
Thornton KE; Chaudhuri M; Monahan SJ; Grinstead LA; Parris DS
Virology; 2000 Sep; 275(2):373-90. PubMed ID: 10998337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
